PortfoliosLab logoPortfoliosLab logo
VBIL vs. PJP
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

VBIL vs. PJP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vanguard 0-3 Month Treasury Bill ETF (VBIL) and Invesco Dynamic Pharmaceuticals ETF (PJP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VBIL achieves a 1.70% return, which is significantly lower than PJP's 7.87% return.


VBIL

1D
0.03%
1M
0.29%
YTD
1.70%
6M
1.81%
1Y
3.91%
3Y*
5Y*
10Y*

PJP

1D
0.70%
1M
3.08%
YTD
7.87%
6M
4.83%
1Y
42.28%
3Y*
15.13%
5Y*
8.22%
10Y*
7.25%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VBIL vs. PJP - Yearly Performance Comparison


Correlation

The correlation between VBIL and PJP is -0.12, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.12

Correlation (All Time)
Calculated using the full available price history since Feb 11, 2025

-0.08

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VBIL vs. PJP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VBIL
VBIL Risk / Return Rank: 100100
Overall Rank
VBIL Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
VBIL Sortino Ratio Rank: 100100
Sortino Ratio Rank
VBIL Omega Ratio Rank: 100100
Omega Ratio Rank
VBIL Calmar Ratio Rank: 100100
Calmar Ratio Rank
VBIL Martin Ratio Rank: 100100
Martin Ratio Rank

PJP
PJP Risk / Return Rank: 8181
Overall Rank
PJP Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
PJP Sortino Ratio Rank: 8585
Sortino Ratio Rank
PJP Omega Ratio Rank: 7676
Omega Ratio Rank
PJP Calmar Ratio Rank: 8585
Calmar Ratio Rank
PJP Martin Ratio Rank: 7777
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VBIL vs. PJP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vanguard 0-3 Month Treasury Bill ETF (VBIL) and Invesco Dynamic Pharmaceuticals ETF (PJP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VBILPJPDifference
Sharpe ratioReturn per unit of total volatility

+15.50

Sortino ratioReturn per unit of downside risk

+108.19

Omega ratioGain probability vs. loss probability

39.66

1.43

+38.23

Calmar ratioReturn relative to maximum drawdown

296.41

4.50

+291.91

Martin ratioReturn relative to average drawdown

1,809.33

14.26

+1,795.07

VBIL vs. PJP - Sharpe Ratio Comparison

The current VBIL Sharpe Ratio is 18.07, which is higher than the PJP Sharpe Ratio of 2.57. The chart below compares the historical Sharpe Ratios of VBIL and PJP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

VBIL vs. PJP - Drawdown Comparison

The maximum VBIL drawdown since its inception was -0.09%, smaller than the maximum PJP drawdown of -37.06%. Use the drawdown chart below to compare losses from any high point for VBIL and PJP.


Loading charts...

Drawdown Indicators


VBILPJPDifference

Max Drawdown

Largest peak-to-trough decline

-0.09%

-37.06%

+36.97%

Max Drawdown (1Y)

Largest decline over 1 year

-0.01%

-9.44%

+9.43%

Max Drawdown (3Y)

Largest decline over 3 years

-16.27%

Max Drawdown (5Y)

Largest decline over 5 years

-17.51%

Max Drawdown (10Y)

Largest decline over 10 years

-33.95%

Current Drawdown

Current decline from peak

0.00%

-1.26%

+1.26%

Average Drawdown

Average peak-to-trough decline

-0.00%

-8.83%

+8.83%

Ulcer Index

Depth and duration of drawdowns from previous peaks

0.00%

2.97%

-2.97%

Volatility

VBIL vs. PJP - Volatility Comparison

The current volatility for Vanguard 0-3 Month Treasury Bill ETF (VBIL) is 0.05%, while Invesco Dynamic Pharmaceuticals ETF (PJP) has a volatility of 5.20%. This indicates that VBIL experiences smaller price fluctuations and is considered to be less risky than PJP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VBILPJPDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.05%

5.20%

-5.15%

Volatility (6M)

Calculated over the trailing 6-month period

0.16%

12.34%

-12.18%

Volatility (1Y)

Calculated over the trailing 1-year period

0.22%

16.54%

-16.32%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

0.30%

16.19%

-15.89%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

0.30%

18.39%

-18.09%

VBIL vs. PJP - Expense Ratio Comparison

VBIL has a 0.07% expense ratio, which is lower than PJP's 0.58% expense ratio.


Dividends

VBIL vs. PJP - Dividend Comparison

VBIL's dividend yield for the trailing twelve months is around 3.65%, more than PJP's 1.19% yield.


PositionTTM20252024202320222021202020192018201720162015
PJP
Invesco Dynamic Pharmaceuticals ETF
1.19%0.98%0.97%1.01%0.95%0.81%0.75%0.77%1.12%0.65%0.91%5.49%
VBIL
Vanguard 0-3 Month Treasury Bill ETF
3.65%3.12%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


VBIL and PJP have a correlation of -0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PJP has higher volatility (5.20%) compared to VBIL (0.05%). In terms of maximum drawdown, VBIL dropped -0.09% vs PJP's -37.06%.

On 1-year performance, PJP leads with 42.28% vs 3.91% for VBIL. On fees, VBIL is cheaper at 0.07% per year. On volatility, VBIL has been the lower-risk option at 0.05%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, PJP has performed better with a 42.28% return vs 3.91%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

VBIL is cheaper with a 0.07% expense ratio, compared with 0.58% for PJP.

VBIL has the higher dividend yield at 3.65%, compared with 1.19% for PJP.

VBIL is categorized as Ultrashort Bond, while PJP is Health & Biotech Equities. VBIL tracks Bloomberg US Treasury Bills 0-3 Months Index, while PJP tracks Dynamic Pharmaceuticals Intellidex Index. They also come from different issuers: Vanguard and Invesco. Their fees differ too: 0.07% for VBIL and 0.58% for PJP.

VBIL currently has the higher Sharpe Ratio (18.07 vs 2.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VBIL and PJP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer